Cadre Bioscience is developing a portfolio of new therapeutics for human diseases of high unmet medical need.

For more information, visit Cadre Bioscience or follow their updates on:

Locations

Cadre Bioscience Articles

In 2019, BioGenerator Invested $3.2 Million in 16 Bioscience Companies in St. Louis

mm
EQ Staff, Jonathan Allen
3 Min Read

BioGenerator’s New Strategies Address St. Louis’ Talent Shortage

mm
St. Louis Post-Dispatch
< 1 Min Read